Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1b/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 Administered to Pediatric Participants With KCNT1-Related Epilepsy

This trial will evaluate the safety, tolerability, pharmacokinetics, and clinical activity of ABS-1230 compared with placebo in participants with KCNT1-related…

KCNT1-Related Epilepsy

Estimated

~$10 – $8,750

Actio Biosciences, Inc.NCT07600736